Showing results (21-30 of 3,590) with videos related to
Sort By:
Pageof 359
Journal of Viral Hepatitis|June 16, 2010
Hepatitis B Virus Genotype G forms core-like particles with unique structural propertiesJ J H Cotelesage, C Osiowy, C Lawrence, et al.Journal of Viral Hepatitis|August 28, 2010
Epidemiology of thrombocytopenia in patients with chronic hepatitis C: more than meets the eyeE G Giannini, V SavarinoJournal of Viral Hepatitis|November 27, 2010
An outbreak of hepatitis B with high mortality in India: association with precore, basal core promoter mutants and improperly sterilized syringesV A Arankalle, S Gandhi, K S Lole, et al.Journal of Viral Hepatitis|November 27, 2010
Hepatitis C treatment among racial and ethnic groups in the IDEAL trialA J Muir, K-Q Hu, S C Gordon, et al.Journal of Viral Hepatitis|February 14, 2009
Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profilesT N Q Pham, S E Mercer, T I MichalakJournal of Viral Hepatitis|February 18, 2009
Low weight predicts neutropenia and peginterferon alfa-2a dose reductions during treatment for chronic hepatitis CY Rotman, L Katz, M Cohen, et al.Journal of Viral Hepatitis|February 19, 2009
A short course of add-on adefovir dipivoxil treatment in lamivudine-resistant chronic hepatitis B patientsR Idilman, S Kaymakoglu, F Oguz Onder, et al.Journal of Viral Hepatitis|September 16, 2010
Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, AustraliaJ Grebely, J Bryant, P Hull, et al.Journal of Viral Hepatitis|March 12, 2011
Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infectionY Liu, C Wang, Y Zhong, et al.Journal of Viral Hepatitis|April 23, 2019
Off-therapy precipitous HBsAg decline predicts HBsAg loss after finite entecavir therapy in HBeAg-negative patientsWen-Juei Jeng, Ming-Ling Chang, Yun-Fan LiawPageof 359